The Goldman Sachs Group Has Lowered Expectations for Silence Therapeutics (NASDAQ:SLN) Stock Price
Silence Therapeutics (NASDAQ:SLN – Free Report) had its price target cut by The Goldman Sachs Group from $4.00 to $3.00 in a report issued on Friday,Benzinga reports. They currently have a sell rating on the stock. SLN has been the topic of a number of other research reports. Morgan Stanley dropped their price objective on […]
Silence Therapeutics (NASDAQ:SLN – Free Report) had its price target cut by The Goldman Sachs Group from $4.00 to $3.00 in a report issued on Friday,Benzinga reports. They currently have a sell rating on the stock. SLN has been the topic of a number of other research reports. Morgan Stanley dropped their price objective on […]
